[VIVO] YoY Quarter Result on 31-Mar-2019 [#Q2]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q2]
Profit Trend
QoQ- -12.48%
YoY- 34.15%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 111,231 85,264 57,296 50,248 56,451 54,125 51,259 13.77%
PBT 36,535 33,052 12,647 9,247 7,224 14,190 14,792 16.25%
Tax 7,783 6,750 3,288 2,153 1,936 4,878 5,701 5.32%
NP 28,752 26,302 9,359 7,094 5,288 9,312 9,091 21.14%
Tax Rate -21.30% -20.42% -26.00% -23.28% -26.80% -34.38% -38.54% -
Total Cost 82,479 58,962 47,937 43,154 51,163 44,813 42,168 11.82%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 25.85 30.85 16.33 14.12 9.37 17.20 17.74 6.47%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS 0.65 0.61 0.22 0.17 0.12 0.22 0.22 19.77%
EPS Diluted 0.65 0.60 0.22 0.17 0.12 0.22 0.21 20.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.